Home \ Expert Opinion \ Mexidol®-Anti-Age (anti-aging) drug

Mexidol®-Anti-Age (anti-aging) drug

Syndrome of attention deficit with hyperactivity as an interdisciplinary problem. Mexidol® children with ADHD

Age continuum of ischemic-hypoxic lesions of the brain. The use of Mexidol for ADHD in children and adults

Rehabilitation after Covid-19

Mexidol®. Rehabilitation after coronavirus

The effectiveness of Mexidol in a comorbid patient: with arterial hypertension, coronary heart disease, brain ischemia

Mexidol's effectiveness in a polymorbid patient

Features of conducting elderly patients in clinical practice

Mexidol®-Anti-Age (anti-aging) drug

Dorsopathy in general clinical practice

Mexidol® with degenerative diseases in the spine, neck pain, dizziness, brain ischemia

Time codes:
  • 00:00

    History of searching for ways to extend life

  • 00:19

    Inflaim theory and connection with the aging process

  • 00:35

    The role of oxidative stress in the development of inflammation

  • 00:45

    Pharmacological and non -pharmacological methods of exposure 

  • 01:01

    Mexidol® as a drug with multimodal effects

  • 01:45

    The ability of the drug Mexidol® to extend life and improve cognitive functions

Pereverzev Anton Pavlovich - Ph.D., Associate Professor of the Department of Therapy and Polymorbid Pathology of the Federal State Budgetary Institution of the DPO RMANPO of the Ministry of Health of Russia

Announcement:

How is aging? What processes are performed at this moment? Science had no answer to these questions for a long time. However, with the advent of the theory of Inflaiming, we approached the explanation of this phenomenon. According to this theory, the aging process and the development of geriatric syndromes are associated with the progression of chronic, aseptic inflammation. This process is aggravated by oxidative stress, which is one of the main causes of inflammation. And here pharmacological and non -pharmacological methods come to the rescue. The drug Mexidol ® was investigated in laboratory tests that showed its ability to extend life. Mexidol® Effect : antioxidant, antihyplance and membranes.

Find out more in the video " Features of the conduct of elderly patients in clinical practice ."

All video next video

Syndrome of attention deficit with hyperactivity as an interdisciplinary problem. Mexidol® children with ADHD

Age continuum of ischemic-hypoxic lesions of the brain. The use of Mexidol for ADHD in children and adults

Rehabilitation after Covid-19

Mexidol®. Rehabilitation after coronavirus

The effectiveness of Mexidol in a comorbid patient: with arterial hypertension, coronary heart disease, brain ischemia

Mexidol's effectiveness in a polymorbid patient

Features of conducting elderly patients in clinical practice

Mexidol®-Anti-Age (anti-aging) drug

Dorsopathy in general clinical practice

Mexidol® with degenerative diseases in the spine, neck pain, dizziness, brain ischemia

Time codes:
  • 00:00

    History of searching for ways to extend life

  • 00:19

    Inflaim theory and connection with the aging process

  • 00:35

    The role of oxidative stress in the development of inflammation

  • 00:45

    Pharmacological and non -pharmacological methods of exposure 

  • 01:01

    Mexidol® as a drug with multimodal effects

  • 01:45

    The ability of the drug Mexidol® to extend life and improve cognitive functions

Block of articles on this topic

The results of an international multicenter randomized double-blind-controlled study of evaluating the effectiveness of the effectiveness and safety of consistent therapy of patients with chronic brain ischemia with Mexidol and Mexidol Forte 250 (study of Memo)

Authors:
A.I. Fedin 1 , V.V. Zakharov 2 , M.M. Tanashian 3 , E.I. Chukanova 1 , E.N. Majidova 4 , L.A. Shchepankevich 5.6 , O.D. Ostroumova 7

Read more
The connection of cellular aging, cardiovascular diseases and anxiety disorders

Author:
A.P. Pereverzev

FSBOU DPO RANMO of the Ministry of Health of Russia

Read more
The effectiveness of Mexidol in patients of different age groups with chronic brain ischemia with cognitive disorders (the results of subanalysis of the international multicenter randomized double blind placebo-controlled study of memes)

Authors:
V.V. Zakharov 1 , O.N. Tkacheva 2, 3 , E.A. Mkhitaryan 2, 3 , A.I. Fedin 2

Read more
Approaches to pharmacotherapy of vascular moderate cognitive disorders in patients of various age groups

Authors:
V.V. Zakharov 1 , A.I. Fedin 2 , E.A. Mkhitaryan 2, 3

Read more
Features of pharmacotherapy of vascular cognitive impairment in elderly people

Author:
A.N. Bogolepova 1, 2

1 FGAOU in Russian National Research Medical University named after N.I. Pirogov »Ministry of Health of Russia, Moscow, Russia;
2 FSBI "Federal Center for Brain and Neurotechnology" of the Federal Medical and Biological Agency of Russia, Moscow, Russia

Read more

Information is intended for medical and pharmaceutical workers. This information cannot serve as a replacement for a doctor’s consultation.

Source of photos and images Shutterstock.com